A cross-sectional analysis evaluated the association of race, ethnicity, and household income with severe outcomes in pediatric vasculitis.

From 2017 to 2022, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) more than doubled, according to a study published online July 17 in the Jour ...

The 2025-2026 SARS-CoV-2 vaccines provided protection against ER and urgent care visits among individuals with COVID-19-like illness.

For patients with peripheral artery disease (PAD) and type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with lower rates of mortality, hospitalization, ...

Real-world data indicate that pegcetacoplan treatment for GA may help patients avoid rapid and catastrophic visual acuity ...

IOP elevation following implantation with a dexamethasone intravitreal device is more severe for patients with particular ...

An analysis shows that insurance-mandated step therapy may inadvertently create "higher-cost, lower-value" care in nAMD.

A class II FDA recall of generic prednisolone acetate ophthalmic suspension eye drops was issued due to the presence of a foreign substance.

A systematic review reveals inconsistent benefits of omega-3 polyunsaturated fatty acid supplementation for patients with dry ...

Credit: Getty Images Andrew D. Pucker, OD, PhD, identifies mechanisms of action behind various myopia control spectacles and highlights their potential to provide myopia control solutions that are ...

A Prescription Drug User Fee Act target date of September 22, 2026 has been set for the application. The Food and Drug Administration (FDA) has granted Priority Review to the New Drug Application (NDA ...